CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,435 enrolled
Drug / intervention
abrupt weaning at 4 months +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00310726
NCT00310726N/ACompleted
CompareCT.gov

Short Duration Exclusive Breastfeeding With Abrupt Weaning to Reduce the Risk of Mother-to-Child HIV Transmission

Boston Medical Center·interventional·Posted Apr 4, 2006·Updated Jul 27, 2011

In Brief

A clinical study evaluating abrupt weaning at 4 months and Continued exclusive breastfeeding for HIV Infection. Completed, enrolled 1,435 participants across 1 site.

Detailed Summary

The study is designed as a randomized, controlled trial with specific observational objectives. All HIV-seropositive pregnant subjects electing to breastfeed their child will be counselled to exclusively breastfeed through 4 months of age. All live-born children will be randomized (1:1) at birth to one of two counseling programs: A) to encourage abrupt weaning at 4 months of age, or B) to encourage exclusive breastfeeding through 6 months of age with the introduction of typical weaning foods ad lib.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infection
CountriesZambia
CollaboratorsUnited States Agency for International Development (USAID), National Institutes of Health (NIH)

Timeline

N/ACompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 4, 2006
Enrollment StartMay 1, 2001
Primary CompletionDec 1, 2006
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 20.2 years ago

Interventions

abrupt weaning at 4 monthsother

abrupt weaning at 4 months

Continued exclusive breastfeedingother

Continued exclusive breastfeeding